These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child. Zheng Y; Nong L; Liang L; Wang W; Li T Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Horny HP; Valent P Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679 [TBL] [Abstract][Full Text] [Related]
7. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282 [TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells. Horny HP; Sotlar K; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676 [TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature. Bernd HW; Sotlar K; Lorenzen J; Osieka R; Fabry U; Valent P; Horny HP J Clin Pathol; 2004 Mar; 57(3):324-8. PubMed ID: 14990611 [TBL] [Abstract][Full Text] [Related]
10. Tryptase a novel biochemical marker of acute myeloid leukemia. Sperr WR; Hauswirth AW; Valent P Leuk Lymphoma; 2002 Dec; 43(12):2257-61. PubMed ID: 12613510 [TBL] [Abstract][Full Text] [Related]
11. Myelomastocytic Leukemia With t(8;21) in a 3-year-old Child. Intzes S; Wiersma S; Meyerson HJ J Pediatr Hematol Oncol; 2011 Dec; 33(8):e372-5. PubMed ID: 22042288 [TBL] [Abstract][Full Text] [Related]
16. Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow. Natkunam Y; Rouse RV Am J Surg Pathol; 2000 Jan; 24(1):81-91. PubMed ID: 10632491 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374 [TBL] [Abstract][Full Text] [Related]
19. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677 [TBL] [Abstract][Full Text] [Related]
20. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Sperr WR; Horny HP; Lechner K; Valent P Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]